← Browse by Condition
Medical Condition

limited stage small cell lung cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05443646 Phase 2
Recruiting

Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients

Enrollment
55 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
View Trial →